Frontage Laboratories, Inc

We’re proud to share that Javed A. Bhalli, MPhil, PhD, ERT, DABT, Vice President at Frontage Laboratories, Inc, has been invited as a speaker for Symposium 2 at #EMGS2025!  At Frontage, we are committed to advancing scientific research, and it’s an honor to have our experts contribute to this important discussion. #FrontageLabs #ScientificResearch #Toxicology #Genomics #GeneTox

🚨 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀 𝗼𝗳𝗳𝗲𝗿𝘀 𝗮 𝗳𝘂𝗹𝗹 𝘀𝘂𝗶𝘁𝗲 𝗼𝗳 𝗣𝗵𝗮𝘀𝗲 𝗜 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀? 🚨 From early-phase clinical research in healthy volunteers to specialized studies in GU/Uro-Oncology, Frontage is your trusted partner for turning innovative ideas into reality. 𝗢𝘂𝗿 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: ✅ Early-phase clinical research in healthy volunteers. ✅ hAME studies and circulating biomarker analysis. ✅ Advanced bioinformatics to support data-driven decision-making. With a track record of delivering quality data and supporting early clinical programs, we’re helping pharmaceutical and biotech companies bridge the gap between preclinical discoveries and real-world applications. 💡 Whether you’re starting your first-in-human study or navigating complex early-phase trials, Frontage is here to help. 📩 Let’s build your path to success. Contact us today: sales@frontagelab.com 📄 Download our Clinical Services Fact Sheet: https://ow.ly/sWaH50V7Gsv

🔬 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗻𝗴 𝗠𝗜𝗦𝗧: 𝗘𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘁𝗲 𝗦𝗮𝗳𝗲𝘁𝘆 & 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 Regulatory agencies expect comprehensive identification and characterization of drug metabolites to ensure non-clinical toxicity is properly evaluated. Meeting 𝗠𝗜𝗦𝗧 (𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝘁𝗲𝘀 𝗶𝗻 𝗦𝗮𝗳𝗲𝘁𝘆 𝗧𝗲𝘀𝘁𝗶𝗻𝗴) guidelines requires detecting all circulating human metabolites, identifying those exceeding 10% total drug-related exposure (TDRE), and demonstrating comparable exposure levels in preclinical species. At Frontage Laboratories, we take the complexity out of MIST compliance with a fully integrated approach that combines in vitro and in vivo assays to address key analytical challenges—no radiotracer required. 👉 Download our latest MIST application note to explore how we help pharmaceutical partners navigate regulatory expectations with precision. https://ow.ly/bX9T50V7gFF #FrontageLabs #MISTGuidelines #ClinicalResearch #Biopharma #DrugMetabolism #RegulatoryCompliance #PharmaceuticalResearch #Toxicology #DrugSafety #DrugDevelopment #DMPK

𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗖𝗠𝗖 𝗔𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗮𝘁 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲 At Frontage Laboratories, we provide CMC Analytical Testing Services to support drug development from early-phase to commercial manufacturing. Our USFDA-inspected labs ensure regulatory compliance, accuracy, and data integrity across a wide range of testing needs. 𝗢𝘂𝗿 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗜𝗻𝗰𝗹𝘂𝗱𝗲𝘀: • Analytical Method Development & Validation (early R&D, Phase-I to commercial) • USP and EP Compendial Testing’s for Finished Drug Products and Raw Materials • In Vitro Release Testing (IVRT) & In Vitro Permeation Testing (IVPT) for skin permeation studies • Nitrosamine Testing • Elemental Impurities analysis • Residual Solvents testing • Extractables & Leachable (E&L) studies • ICH Stability Storage & Testing • In-vitro Drug Release /Dissolution Studies • Microbiology Testing (Sterility, Bioburden, Endotoxin) • Disinfectant Studies • Large molecules testing (Biologics, Cell and Gene Therapy Products) • Supporting all BLA, NDA and ANDA filing requirements. • Container Closure Integrity Studies for Sterile dosage form products. With our cutting-edge technology, regulatory expertise, and dedicated team, we help our partners navigate complex analytical challenges to bring high-quality therapies to patients. 📩 Looking for a trusted CMC analytical partner? Talk to our experts today followed by connect us at Sales@frontagelab.com #FrontageLabs #PharmaceuticalTesting #BiotechIndustry #CMC #CDMO #CROServices #MicrobiologyTesting #Biopharmaceuticals #GMP #GLP #RegulatoryCompliance #USFDA

🌍 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝘄𝗶𝘁𝗵 𝗢𝘂𝗿 𝗚𝗹𝗼𝗯𝗮𝗹 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 At Frontage 𝗚𝗹𝗼𝗯𝗮𝗹 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 (𝗚𝗗𝗗𝗦), we deliver customer-centric, science-driven, end-to-end drug discovery solutions. With a global team of 400+ experts in medicinal chemistry, biology, pharmacology, and DMPK, we support every stage of discovery, from hit-to-lead and lead optimization to the advancement of development candidates. 𝗪𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝘁𝗵𝗲 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴: ▪️ Fully integrated discovery projects with chemistry (all modalities including PROTAC), bioassays, ADME/T screening and PK-PD relationship ▪️ On-demand projects for ADME, hERG, bioanalysis, pharmacology and chemistry ▪️ MOA studies & signaling pathways with protein degradation and FACS analysis ▪️ In vivo imaging with animal models and tumor efficacy models ▪️ 250+ cancer cell lines & tumor models, 275+ kinases, 100+ GPCR cell panel 🔬 To learn more download our latest fact sheet: https://lnkd.in/ekrSJm53 📧 Contact us: sales@frontagelab.com #DrugDiscovery #MedicinalChemistry #Pharmacology #DMPK #LeadOptimization #FrontageLabs #GDDS

🚀𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲 𝗘𝗨 𝗟𝗮𝗯 𝗶𝗻 𝗡𝗲𝗿𝘃𝗶𝗮𝗻𝗼, 𝗜𝘁𝗮𝗹𝘆, 𝗔𝗰𝗵𝗶𝗲𝘃𝗲𝘀 𝗚𝗟𝗣 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻! We’re thrilled to announce that 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲’𝘀 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗶𝗻 𝗡𝗲𝗿𝘃𝗶𝗮𝗻𝗼, 𝗜𝘁𝗮𝗹𝘆, 𝗶𝘀 𝗻𝗼𝘄 𝗚𝗟𝗣-𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗲𝗱 for Bioanalysis and Pharmacokinetics! This milestone strengthens our global capabilities in 𝗗𝗠𝗣𝗞, 𝗿𝗮𝗱𝗶𝗼𝘀𝘆𝗻𝘁𝗵𝗲𝘀𝗶𝘀 𝗹𝗮𝗯𝗲𝗹𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗯𝗶𝗼𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀, ensuring high-quality, regulatory-compliant research to accelerate drug development. With this certification, our Nerviano facility becomes a premier hub for preclinical studies, supporting drug discovery and regulatory submissions with data integrity and reproducibility at the highest standards. As Frontage’s global footprint expands, we’re committed to providing fully integrated services across North America, Europe, Asia and beyond. Need DMPK, radiosynthesis labeling, or bioanalytical support? Let’s collaborate on your next breakthrough! 📧 Want to learn more? Let’s connect: sales@frontagelab.com #Frontage #GLP #DMPK #Bioanalysis #Radiosynthesis #DrugDevelopment #Global #DrugDiscovery #AnimalStudies

At Frontage, our Genomics Services team uses advanced technologies and state-of-the-art equipment to provide fast, accurate, and customized results you can trust. With two facilities located in the United States, we are CLIA-certified, CAP-accredited and meet all GLP regulatory standards. We offer pre-validated NGS-based LTDs for oncology and pharmacogenomics that are CAP-accredited. Custom NGS, qPCR, or droplet digital PCR assays can be set up and validated under GLP or CLIA as well. 👉Download our latest fact sheet to learn more: https://lnkd.in/eWBJJXDF Interested in connecting with one of our experts? Email us at sales@frontagelab.com #genomics #assays #cro #drugdevelopment #drugdiscovery

𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲 𝗕𝗶𝗼𝗰𝗼𝗺𝗽𝗮𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 & 𝗥𝗼𝘂𝘁𝗶𝗻𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗮𝘁 𝗡𝘂𝗰𝗿𝗼-𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝘀, 𝗮 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 Ensuring medical device safety and compliance is essential for regulatory approval and product success. Nucro-Technics Inc., a Frontage company, offers a comprehensive suite of biocompatibility testing services, fully compliant with ISO10993 standards and GMP/GLP regulations. Our customized testing approach delivers accurate and reliable results, ensuring each medical device meets regulatory and performance requirements. 𝗢𝘂𝗿 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 𝗜𝗻𝗰𝗹𝘂𝗱𝗲: 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹 𝗕𝗶𝗼𝗰𝗼𝗺𝗽𝗮𝘁𝗶𝗯𝗶𝗹𝗶𝘁𝘆 (𝗜𝗦𝗢 𝟭𝟬𝟵𝟵𝟯) - Cytotoxicity, Sensitization, Genotoxicity, Hemocompatibility & more. 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 & 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 – Sterilization Cycle Validation, Microbial Evaluation, LAL/Particulate Analysis 𝗥𝗼𝘂𝘁𝗶𝗻𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 – Release Testing, Finished Product Qualification, Microbiology Testing 🌍𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗼𝗻 𝘁𝗵𝗲 𝗡𝘂𝗰𝗿𝗼-𝗧𝗲𝗰𝗵𝗻𝗶𝗰𝘀 𝘄𝗲𝗯𝘀𝗶𝘁𝗲: https://lnkd.in/eXWBp-ph 📩𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲! sales@frontagelab.com #MedicalDevices #BiocompatibilityTesting #ISO10993 #RegulatoryCompliance #GMP #GLP #FrontageLabs #NucroTechnics  #2025SOT #ToxExpo

𝗠𝗲𝗲𝘁 𝗨𝘀 𝗮𝘁 𝘁𝗵𝗲 𝟮𝟬𝟮𝟱 𝗕𝗼𝘀𝘁𝗼𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗚&𝗖𝗧 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲! We’re excited to be at the 𝟮𝟬𝟮𝟱 𝗕𝗼𝘀𝘁𝗼𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗚𝗲𝗻𝗲 & 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 on March 20-21, 2025 at Bristol Myers Squibb, Cambridge, MA! Visit us at 𝗕𝗼𝗼𝘁𝗵 #𝟮 to learn more about our Gene & Cell Therapy services and how we can support your development needs. 📩 𝗕𝗼𝗼𝗸 𝗮 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝘁𝗼𝗱𝗮𝘆! 𝘀𝗮𝗹𝗲𝘀@𝗳𝗿𝗼𝗻𝘁𝗮𝗴𝗲𝗹𝗮𝗯.𝗰𝗼𝗺 #Frontage #BSGCT2025 #GeneTherapy #CellTherapy #GCT #Genetics #LifeSciences #PharmaConference #BostonConference #DrugDevelopment #Biotech #LifeSciences #Innovation #CRO

At 𝗙𝗿𝗼𝗻𝘁𝗮𝗴𝗲 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝗶𝗲𝘀, we understand that microbiological safety is critical in pharmaceutical, biotech, and medical device development. Our GLP and cGMP-compliant Microbiological Testing Services provide comprehensive solutions to ensure product quality, regulatory compliance, and patient safety. We support Bioburden testing for Finished drug products, Release testing's, Stability testing’s, In-process Testing, Raw materials, Biologicals, Cell & Gene therapies, Device combinations and many more! 𝗞𝗲𝘆 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗖𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀: ✔ USFDA -Inspected Labs ✔ Microbial Limits Testing (USP <60>, <61>, <62>) ✔ Antimicrobial Effectiveness Testing (AET) (USP <51>) ✔ Disinfectant Studies ✔ Sterility Testing (USP <71>) ✔ Bacterial Endotoxins Test (BET) (USP <85>) 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗲𝘁𝗵𝗼𝗱𝘀: ✔Suitability Testing: MLT and AET ✔Inhibition/Enhancement Testing: BET ✔Bacteriostasis/Fungistasis Testing: Sterility With state-of-the-art facilities and an experienced microbiology team, we help ensure your products meet the highest regulatory standards. 🔗 Learn more: https://ow.ly/tj0t50V33Ge 📧 Contact Us: sales@frontagelab.com #MicrobiologicalTesting #BioburdenTesting #GLP #GMP #QualityControl #PharmaTesting #FrontageLabs #CDMO #SterilityTesting #USFDA #LabTesting #RegulatoryCompliance #AsepticProcessing #EndotoxinTesting #EnvironmentalMonitoring